Rezulin – Alliance for Human Research Protection

September 27, 2014

David Graham, MD

David Graham, MD, FDA’s Associate Director of Science and Medicine who, throughout his career, has been a

David Graham, MD

October 7, 2012

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

IV. What Do We Get for All That Money? According to the Kaiser Foundation:[1] The number of

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

September 15, 2012

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

Is US Healthcare Really the best in the World? Starfield_JAMA_2000 The findings by Barbara Starfield, MD, of

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

September 14, 2012

Safety Issues: FDA Scientists Collide with FDA Managers

EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership: · In 1995, Dr. Leo

Safety Issues: FDA Scientists Collide with FDA Managers

September 8, 2012

FDA Scientists Collide with FDA Managers Re: Safety Issues

EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership: In 1995, Dr. Leo Lutwak,

FDA Scientists Collide with FDA Managers Re: Safety Issues

August 20, 2012

Rx Drugs Recalled for Safety Issues from US market

FDA Drug Recall Due to Safety Issues 1980 – 2011 Drug Name: Approved Withdrawn Methaqualone

Rx Drugs Recalled for Safety Issues from US market

January 26, 2007

Bayer Settles Baycol AG Stuits $8 million

At least 100 people died because of the failure of Bayer to disclose thelethal risks of its

Bayer Settles Baycol AG Stuits $8 million

January 22, 2007

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Role of Litigation in Defining Drug Risks_JAMA / BMJ

October 26, 2006

FDA’s Double Standard Re: Advisory Committee Membership

FDA’s Double Standard Re: Advisory Committee Membership Mon, 15 Nov 2004 FDA’s inexplicable actions–the latest being the

FDA’s Double Standard Re: Advisory Committee Membership

October 26, 2006

FDA’s Lethal Weakness Requires More than Committees

FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York

FDA’s Lethal Weakness Requires More than Committees

October 26, 2006

FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle

FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and

FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle

October 26, 2006

How Did the Vioxx Debacle Happen? USA Today / Lancet

How Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol

How Did the Vioxx Debacle Happen? USA Today / Lancet

October 26, 2006

Trial Lawyers Are Taking Aim at the Drug Industry_NYT

Trial Lawyers Are Taking Aim at the Drug Industry_NYT Sun, 18 May 2003 It appears that trial

Trial Lawyers Are Taking Aim at the Drug Industry_NYT

October 26, 2006

Drug Warnings: Are They Effective? USA Today

Drug Warnings: Are They Effective? USA Today Tue, 26 Apr 2005 How effective are drug warnings? USA

Drug Warnings: Are They Effective? USA Today

Load More Articles

ALLIANCE FOR HUMAN RESEARCH PROTECTION

David Graham, MD

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

Safety Issues: FDA Scientists Collide with FDA Managers

FDA Scientists Collide with FDA Managers Re: Safety Issues

Rx Drugs Recalled for Safety Issues from US market

Bayer Settles Baycol AG Stuits $8 million

Role of Litigation in Defining Drug Risks_JAMA / BMJ

FDA’s Double Standard Re: Advisory Committee Membership

FDA’s Lethal Weakness Requires More than Committees

FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle

How Did the Vioxx Debacle Happen? USA Today / Lancet

Trial Lawyers Are Taking Aim at the Drug Industry_NYT

Drug Warnings: Are They Effective? USA Today

Subscribe to Our Newsletter!